here is a new migraine drug in development: anti-CGRP antibody. It functions by enlarging the blood vessel and releases the symptoms.

originally developed in Pfizer, outsourced and later acquired by Teva for a total of 800million.

Just had a very successful Phase II clinical trial, might be on the market in a couple of years.
[url=http://www.firstwordpharma.com/node/1270739#axzz3ZTpPgLrW]http://www.firstwordpharma.com/node/1270739#axzz3ZTpPgLrW[/url]